Healthcare -
Biotechnology - NASDAQ - US
$ 1.14
-1.72 %
$ 6.11 M
Market Cap
-0.09
P/E
DRMA - COST OF REVENUE
Cost of Revenue DRMA - Dermata Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR